Inhibition of cell growth and bcl-2 expression in aggressive B-cell lymphomas by retinoic acid.

被引：0
|
作者：
Sundaresan, A
Claypool, CK
LopezBerestein, G
Cabanillas, F
Ford, RJ
机构：
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PATHOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MED,HOUSTON,TX 77030
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2400 / 2400
页数：1
相关论文
共 50 条
  • [41] Phase I study of the Bcl-2 inhibitor venetoclax with DA-EPOCH-R as initial therapy for aggressive B-cell lymphomas.
    Rutherford, Sarah C.
    Abramson, Jeremy S.
    Bartlett, Nancy L.
    Barta, Stefan K.
    Khan, Nadia
    Joyce, Robin
    Maddocks, Kami J.
    Yuan, Ying
    Ali-Shaw, Trisha
    Senese, Silvia
    Westin, Jason
    Leonard, John Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] The major subtypes of human B-cell lymphomas lack mutations in BCL-2 family member BAD
    Schmitz, Roland
    Thomas, Roman K.
    Harttrampf, Anne C.
    Wickenhauser, Claudia
    Schultze, Joachim L.
    Hausmann, Martin-Leo
    Wolf, Juergen
    Kueppers, Ralf
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1738 - 1740
  • [43] Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas
    McCarthy, Aine
    Clear, Andrew James
    Marzec, Jacek
    Coutinho, Rita
    Petty, Robert D.
    Matthews, Janet
    Wilson, Andrew
    Iqbal, Sameena
    Calaminici, Maria
    Gribben, John G.
    Jia, Li
    BLOOD, 2014, 124 (21)
  • [44] Evaluation of bcl-2 expression in aggressive and non-aggressive basal cell carcinomas
    Amini, Elham
    Salehian, Pirooz
    VIRCHOWS ARCHIV, 2008, 452 : S41 - S41
  • [45] bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas
    Ramdial, PK
    Madaree, A
    Reddy, R
    Chetty, R
    JOURNAL OF CUTANEOUS PATHOLOGY, 2000, 27 (06) : 283 - 291
  • [46] Correlation of chromosome 18 aberrations and Bcl-2/Igh rearrangements with defined entities for B-cell lymphomas
    Karlic, HI
    Nowotny, H
    Jaeger, U
    Gruner, H
    Nader, A
    Vesely, M
    Schlogl, E
    Heinz, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1246 - 1246
  • [47] B-cell overexpression of Bcl-2 cooperates with p21 deficiency for the induction of autoimmunity and lymphomas
    Santiuste, Ines
    Buelta, Luis
    Iglesias, Marcos
    Genre, Fernanda
    Mazorra, Francisco
    Izui, Shozo
    Merino, Jesus
    Merino, Ramon
    JOURNAL OF AUTOIMMUNITY, 2010, 35 (04) : 316 - 324
  • [48] Evaluation of bcl-2 expression in aggressive and non-aggressive basal cell carcinomas
    Amini, E.
    Salehian, P.
    VIRCHOWS ARCHIV, 2009, 455 : 52 - 52
  • [49] Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas
    Kawasaki, C
    Ohshima, K
    Suzumiya, J
    Kanda, M
    Tsuchiya, T
    Tamura, K
    Kikuchi, M
    LEUKEMIA & LYMPHOMA, 2001, 42 (05) : 1099 - 1106
  • [50] Clinical Implications of CD30 Expression in Aggressive B-Cell Lymphomas
    Malysz, Jozef
    Erdman, Patrick
    Klapper, Jeremy
    Zhu, Junjia
    Creer, Michael
    Bayerl, Michael G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (08): : 429 - 433
12345